In a recent head-to-head study involving Novo Nordisk 's Wegovy, Zepbound came out on top, resulting in average weight loss ...

EP0031/A400 is being developed jointly by Ellipses in a global clinical phase 1/2 trial under the name EP0031 (NCT05443126) and Kelun Biotech (6990.HK) in China under the name A400 (NCT05265091).

The battles over abortion in the U.S. are increasingly focusing on the pills that are now the most common way pregnancies are ...

The Japanese c ...

European stocks opened lower, mirroring last week's decline, with travel and media sectors lagging. Novo Nordisk rebounded ...